MANCHESTER, England and VIENNA, April 12, 2021 /PRNewswire/ -- F2G Limited ("F2G"), a clinical-stage biopharmaceutical company focused on life threatening fungal diseases, announces that Francesco ...
Products Market Alerts MyCollection Price Database Become a Partner Gallery ...
- Brings substantial pharmaceutical expertise to lead the development and commercialization of olorofim in the USA - Ian Nicholson stepping down to pursue non-executive roles MANCHESTER, England and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results